title: Phase 3 trials suggest ways to improve current hematologic cancer therapies.
authors.forename: Tracy
authors.initials: T
authors.lastname: Hampton
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D009101:Multiple Myeloma / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents